Case Reports

55-year-old woman • unilateral nasal drainage • salty taste • nasal redness • recent COVID-19 nasal swabs • Dx?

Author and Disclosure Information

► Unilateral nasal drainage
► Salty taste
► Nasal redness
► Recent COVID-19 nasal swabs


 

References

THE CASE

A 55-year-old woman was evaluated in a family medicine clinic for clear, right-side nasal drainage. She stated that the drainage began 5 months earlier after 2 hospitalizations for severe anxiety leading to emesis and hypokalemia. She reported 3 different COVID-19 nasal swab tests performed on the right nare. Chart review showed 2 negative COVID-19 tests, 6 days apart. Since the hospitalizations, the patient had been given antihistamines for rhinorrhea at an urgent care visit. Despite this treatment, the patient reported a constant drip from the right nare with a salty taste. She also reported experiencing occasional headaches but denied nausea/vomiting.

The patient’s history included uncontrolled hypertension, treatment-resistant anxiety and depression, obstructive sleep apnea, chronic sinus disease (observed on computed tomography [CT] scans), and type 2 diabetes. She was on amlodipine 10 mg/d for hypertension and was not taking any medication for diabetes.

On examination, the patient’s vital signs were within normal limits except for an elevated blood pressure of 158/88 mm Hg. The patient had persistent clear rhinorrhea fluid draining from the right nostril that was exacerbated when she looked down. Right nasal erythema was present.

THE DIAGNOSIS

The patient’s negative COVID-19 tests, lack of improvement on antihistamines, and description of the nasal fluid as salty tasting prompted us to suspect a cerebrospinal fluid (CSF) leak. The clinical work-up included a halo (“double-ring”) sign test, a β-2 transferrin test, and a sinus x-ray.

The halo sign test was negative for CSF fluid. Sinus/skull x-ray did not show a cribriform or other fracture. However, a sample of the nasal fluid collected in a sterile container was positive for β-2 transferrin, the gold-standard laboratory test to confirm a CSF leak.

The patient was sent for a maxillofacial CT scan without contrast. Results showed a 3-mm defect over the right ethmoid roof associated with a 10 × 16–mm low-attenuation structure in the right ethmoid labyrinth, suspicious for encephalocele. This defect, in the setting of the patient’s history of chronic sinus disease, furthered our suspicion of a CSF leak secondary to COVID-19 testing. Radiology confirmed the diagnosis.

DISCUSSION

CSF rhinorrhea is CSF leakage through the nasal cavity due to abnormal communication between the arachnoid membrane and nasal mucosa.1 The most commonly reported risk factors for this include female sex, middle age (fourth to fifth decade), obesity (body mass index > 40), intracranial hypertension, and obstructive sleep apnea.1,2

Continue to: Clear, unilateral rhinorrhea...

Pages

Recommended Reading

Ancient plague, cyclical pandemics … history lesson?
MDedge Family Medicine
Positive top-line results for cannabinoid-based med for nerve pain
MDedge Family Medicine
Potential new treatment for REM sleep behavior disorder
MDedge Family Medicine
Flavanol supplement improves memory in adults with poor diets
MDedge Family Medicine
Game-changing Alzheimer’s research: The latest on biomarkers
MDedge Family Medicine
Gout linked to smaller brain volume, higher likelihood of neurodegenerative diseases
MDedge Family Medicine
Blood biomarker may help predict who will develop Alzheimer’s
MDedge Family Medicine
Muscle fat: A new risk factor for cognitive decline?
MDedge Family Medicine
FDA panel unanimously endorses lecanemab for Alzheimer’s
MDedge Family Medicine
Caring for the caregiver in dementia
MDedge Family Medicine